A recent study reports that coronary artery calcification (CAC) predicts the risk of heart failure, myocardial infarction and stroke in patients with moderate chronic kidney disease (CKD). This finding suggests that even in CKD, CAC is a marker of cardiovascular risk rather than a benign indicator of vessel healing and stability.
This is a preview of subscription content, log in via an institution to check access.
References
Chen, J. et al. Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease. JAMA Cardiol. http://dx.doi.org/10.1001/jamacardio.2017.0363 (2017).
Shaalan, W. et al. Degree of carotid plaque calcification in relation to symptomatic outcome and plaque inflammation. J. Vasc. Surg. 40, 262–269 (2004).
Huang, H. et al. The impact of calcification on the biomechanical stability of atherosclerotic plaques. Circulation 103, 1051–1056 (2001).
Block, G. A., Raggi, P., Bellasi, A., Kooienga, L. & Spiegel, D. M. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int. 71, 438–441 (2007).
Jamal, S. A. et al. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet 38, 1268–1277 (2013).
Nakamura, S. et al. Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin. J. Am. Soc. Nephrol. 4, 1892–1900 (2009).
Kitamura, K. et al. Relationship between cardiac calcification and left ventricular hypertrophy in patients with chronic kidney disease at hemodialysis initiation. Heart Vessels http://dx.doi.org/10.1007/s00380-017-0969-4 (2017).
Ananthapanyasut, W. et al. Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease.Clin. J. Am. Soc. Nephrol. 5, 173–181 (2010).
Sugiyama, T. et al. Impact of chronic kidney disease stages on atherosclerotic plaque components on optical coherence tomography in patients with coronary artery disease. Cardiovasc. Interv. Ther. http://dx.doi.org/10.1007/s12928-016-0408-y (2016).
Baigent, C. et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomized placebo-controlled trial. Lancet 377, 2181–2192 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
P.R. has received speaker's honoraria and research funding from Amgen, Sanofi and Genzyme.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Raggi, P. Coronary artery calcification predicts risk of CVD in patients with CKD. Nat Rev Nephrol 13, 324–326 (2017). https://doi.org/10.1038/nrneph.2017.61
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2017.61
- Springer Nature Limited
This article is cited by
-
Predictive role of cardiac valvular calcification in all-cause mortality of Chinese initial haemodialysis patients: a follow-up study of 4 years
BMC Nephrology (2023)
-
Echocardiographic manifestations in end-stage renal disease
Heart Failure Reviews (2023)
-
The crosstalk between endothelial cells and vascular smooth muscle cells aggravates high phosphorus-induced arterial calcification
Cell Death & Disease (2022)
-
Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches
Journal of Molecular Medicine (2021)
-
Upregulation of miR-223 abrogates NLRP3 inflammasome-mediated pyroptosis to attenuate oxidized low-density lipoprotein (ox-LDL)-induced cell death in human vascular endothelial cells (ECs)
In Vitro Cellular & Developmental Biology - Animal (2020)